SITAGLIPTINE Metformine Sandoz 50/850mg 196 pce
7680687230049
CH-68723
A10BD07
07.06.2.
Reimbursement limitations:
JANUMET3
Pour le traitement des patients diabétiques de type 2 qui ne peuvent pas être suffisamment …
1 / 3
google
Details
- Product number
- 6872302
- CPT
- -
- Packaging group
- 196
- Unit
- Tablette(n)
- Composition
- metformini hydrochloridum 850 mg, sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50 mg, povidonum K 30, natrii laurilsulfas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: hypromellosum, hydroxypropylcellulosum, triethylis citras, E 171, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 2.99 mg.
Articles (1)
Sitagliptin Metformin Sandoz 50 mg/850 mg, Filmtabletten
Filmtabletten
196
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
850.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
2.99 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 52.60
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2023
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68723
- Drug name
- Sitagliptin Metformin Sandoz, Filmtabletten
- Galenic form
- FILM
- ATC Code
- A10BD07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/09/2022
- Authorization expiration date
- 07/09/2027
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SITAGLIPTINE Metformine Sandoz 50/850mg 196 pce
- Description (DE)
- SITAGLIPTIN Metformin Sandoz 50/850mg 196 Stk
- Market launch
- 08/09/2022
- Narcotic (BTM)
- No